| Targeting rearranged during transfection in cancer: A perspective on small-molecule inhibitors and their clinical development D Saha, KR Ryan, NR Lakkaniga, B Acharya, NG Garcia, EL Smith, ... Journal of medicinal chemistry 64 (16), 11747-11773, 2021 | 22 | 2021 |
| FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms B Acharya, D Saha, D Armstrong, NR Lakkaniga, B Frett RSC Medicinal Chemistry 13 (7), 798-816, 2022 | 14 | 2022 |
| Hands-on electrospray ionization mass spectrometry for undergraduate biochemistry students: peptide identification by ladder sequencing V Perera, B Acharya, AL Patrick, D Mlsna Journal of Chemical Education 97 (5), 1437-1442, 2020 | 10 | 2020 |
| A combined infrared ion spectroscopy and computational chemistry study of hydroxyproline isomers B Acharya, W Kaushalya, J Martens, G Berden, J Oomens, AL Patrick Journal of the American Society for Mass Spectrometry 31 (6), 1205-1211, 2020 | 9 | 2020 |
| Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma M McCrury, K Swafford, SL Shuttleworth, SH Mehdi, B Acharya, D Saha, ... Molecular cancer therapeutics 23 (3), 316-329, 2024 | 4 | 2024 |
| Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group K Swafford, B Acharya, YZ Xu, T Raney, M McCrury, D Saha, B Frett, ... Genes 13 (7), 1144, 2022 | 3 | 2022 |
| Targeting TGF-β: triumphs and challenges B Acharya, S Miah, B Frett Future Medicinal Chemistry 14 (7), 455-458, 2022 | 3 | 2022 |
| An updated patent review of rearranged during transfection (RET) kinase inhibitors (2016–present) B Acharya, B Frett Expert Opinion on Therapeutic Patents 32 (10), 1067-1077, 2022 | 2 | 2022 |
| Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules B Acharya, D Saha, D Armstrong, M Hanafi, A Herrera-Rueda, ... RSC Medicinal Chemistry 15 (2), 399-415, 2024 | 1 | 2024 |
| Dichloroacetyl chloride conjugated peptide-based probes: design, synthesis, and in vitro evaluation in breast cancer cells R Joshi, B Acharya, K Bhandari, S Bhandari, R Duwal, R Ghimire, ... International Journal of Polymeric Materials and Polymeric Biomaterials 70 …, 2021 | 1 | 2021 |
| Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441 ZJ Waldrip, B Acharya, D Armstrong, M Hanafi, RR Rainwater, S Amole, ... Scientific Reports 14 (1), 19999, 2024 | | 2024 |
| Attenuation of renal injury by administration of TK-850, a dual inhibitor of TGFβR1/MAP4K4 H Palfrey, S Goorani, A Sharma, B Acharya, B Frett, J Imig Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024 | | 2024 |
| Discovery of 9H-pyrimido [4, 5-b] indole derivatives as dual RET/TRKA inhibitors B Acharya, D Saha, NG Garcia, D Armstrong, M Hanafi, B Frett, KR Ryan Bioorganic & Medicinal Chemistry 106, 117749, 2024 | | 2024 |
| 557 Dual TGFβR1/MAP4K4 inhibitor reduces kidney injury in a mouse model of renal fibrosis. HA Palfrey, S Goorani, A Sharma, B Acharya, B Frett, JD Imig Journal of Clinical and Translational Science 8 (s1), 166-166, 2024 | | 2024 |
| 443 Team Science S Miah, B Acharya, MN Huda, B Frett Journal of Clinical and Translational Science 7 (s1), 131-131, 2023 | | 2023 |
